InvestorsHub Logo
Followers 13
Posts 1682
Boards Moderated 0
Alias Born 04/19/2011

Re: PNKBULLSHT post# 1236

Tuesday, 05/03/2011 10:01:29 AM

Tuesday, May 03, 2011 10:01:29 AM

Post# of 65770
NEWS

SOHM, Inc. Announces Surge in Demand for Its Generic Pharmaceuticals Within India
05/03/2011 09:02:22 ET
India's Generic Drug Market Projected to Grow at a CAGR of Around 16.3% During FY 2011-FY 2013
BUENA PARK, CA, May 03, 2011 (MARKETWIRE via COMTEX News Network) -- SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that demand for its branded pharmaceutical products has surged within India. In line with the Company's growth target of 200% in 2011 new product offerings and expanding market share are expected to drive sales.

India is considered one of the fastest growing pharmaceutical markets in the world. The introduction of new products coming off patent protection has put the industry growth on a new path. Research report "Booming Generics Drug Market in India," has the generic drug market in India projected to grow at a CAGR of around 16.3% during FY 2011-FY 2013.

"Blockbuster drugs continue to lose their patent protection which creates a constant new product pipeline for generic drug manufacturers like SOHM," stated Shailesh Shah, President and CEO of SOHM, Inc. "Asthma treatment, Advair and anti-cholesterol pill, Lipitor have both recently lost patent protection which has been a significant new area of growth for our Company. Demand in emerging markets like India for affordable drugs continues to ramp up and there is no denying the scale of the opportunity these markets present. Research analysts continue to point at population growth in emerging markets, but what is important is rising demand driven by the increasing middle classes and their increasing appetite for affordable high quality drugs."

About SOHM, Inc. SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For more information, please contact:
SOHM, Inc.
Investor Relations
(714) 522-6700
Email Contact
SOURCE: SOHM, Inc.

http://www2.marketwire.com/mw/emailprcntct?id=942AAEE28141BA3A
Copyright 2011 Marketwire, Inc., All rights reserved.